Topic: AI/GenAI
Technology Trend, Impacts and Opportunities
Speaker: Roger
Liao, Partner, iD Ventures America
Time: 2024.4.16
(Tue) 14:00-16:00
Venue: CGU Artificial
Intelligence Research Center (Management Building 11F)
Join Online: https://reurl.cc/bV48ml
About
the Speaker:
Prof. Su-Wei Chang currently serves
as an Associated Professor in the Department of Artificial Intelligence, Chang
Gung University. She accquired a PhD in Applied mathematics and Statistics from
State University of New York, Stony Brook, USA in 2009. She then spent two
years doing postdoctoral research in Institute of Biomedical Sciences, Academia
Sinica. And she joined Clinical Informatics and Medical Statistics Research
Center, Chang Gung University in 2011.
Prof. Su-Wei Chang’s research
specialties and directions include the application of statistical methods and
artificial intelligence (AI) technologies in clinical and biomedical data, as
well as the development of new statistical and AI-assisted analytical methods.
Main focus includes: (1) multi-omics data analysis, such as genomics,
proteomics, metabolomics data, and bioinformatics analysis in various diseases.
(2) integration of omics and clinical data to construct clinical evaluation and
disease prediction models. (3) big health data analysis, such as biobanks and
health insurance databases through AI and longitudinal statistical analysis
methods to develop analytical strategies and evaluation models for precision
medicine.
Talk Abstract:
In 2016, AlphaGo's resounding victory over the
world Go champion sparked a surge in AI investment. Six years later the advent
of LLMs/GenAI, exemplified by OpenAI’s ChatGPT, stunned the world again,
reaching a record 100 million users in just two months. Now, leading
industry figures predict when AGI will arrive, with ethical concerns
surrounding its development, such as misuse, intellectual property, and
misinformation, plus likely jobs losing. The speaker will share his view on
this from what he has learnt in the past. Moreover, what is its impact on
each sector of the industry and the individuals? The high-tech industry has
shifted from FAAMG to Mt. MANTAG AIOS. Is this a hype? GenAI in fact is an
enabler of AI and it makes the impossible possible. What applications that
industry is focus on? What’s the trend? Among others, Edge AI, Robotic
Process Automation (RPC), and even no-code/low-code have constantly been
mentioned for a long time but only until now they become a highly achievable
reality. New computer/cloud architecture and extremely low power consumption solutions
seem to be a necessity. As a venture capitalist, the speaker has been
“soul-searching” trying to answer himself on questions such as, what kind of
GenAI startups he would invest? With is, the recent Venture Capital (VC)
investments in GenAI startups and their future interests will be covered. He
will also take you to peep at current GenAI-related business as examples when
possible. In addition, while Transformer-based LLMs have revolutionized the
field over RNNs, there are still limitations to address. What’s the
possible technological advancement which could propel the industry forward to
the next level? This is an open question for everyone to consider. The
opportunities may then follow.
Organizers: College of Intelligent Computing &
Artificial Intelligence Research Center
※ No registration needed.